Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNovacyt Regulatory News (NCYT)

Share Price Information for Novacyt (NCYT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.40
Ask: 66.00
Change: -1.50 (-2.27%)
Spread: 2.60 (4.101%)
Open: 64.00
High: 64.00
Low: 64.00
Prev. Close: 66.20
NCYT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Yourgene Health plc

8 Sep 2023 12:00

RNS Number : 8668L
Stifel Nicolaus Europe Limited
08 September 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Stifel Nicolaus Europe Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Yourgene Health plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Yourgene Health plc

(d) Date dealing undertaken:

07 September 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Buy

587,379

0.5126 GBX

0.5126 GBX

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

08 September 2023

Contact name:

Jordan Gaskell

Telephone number:

0207 710 7482

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEREAPNPEFLDEEA
Date   Source Headline
2nd Mar 20201:15 pmRNSLiquidity Agreement Update and Total Voting Rights
28th Feb 20204:40 pmRNSSecond Price Monitoring Extn
28th Feb 20204:35 pmRNSPrice Monitoring Extension
28th Feb 20207:00 amRNSCoronavirus test update
26th Feb 20207:04 amRNSSecond Price Monitoring Extn
26th Feb 20207:00 amRNSPrice Monitoring Extension
25th Feb 20209:05 amRNSSecond Price Monitoring Extn
25th Feb 20209:00 amRNSPrice Monitoring Extension
24th Feb 20209:05 amRNSSecond Price Monitoring Extn
24th Feb 20209:00 amRNSPrice Monitoring Extension
21st Feb 202011:05 amRNSSecond Price Monitoring Extn
21st Feb 202011:00 amRNSPrice Monitoring Extension
20th Feb 20204:35 pmRNSPrice Monitoring Extension
20th Feb 202011:05 amRNSSecond Price Monitoring Extn
20th Feb 202011:00 amRNSPrice Monitoring Extension
20th Feb 20209:05 amRNSSecond Price Monitoring Extn
20th Feb 20209:00 amRNSPrice Monitoring Extension
19th Feb 20205:30 pmRNSFinal Warrant Exercise and Issue of Equity
19th Feb 20204:41 pmRNSSecond Price Monitoring Extn
19th Feb 20204:35 pmRNSPrice Monitoring Extension
19th Feb 20202:05 pmRNSSecond Price Monitoring Extn
19th Feb 20202:00 pmRNSPrice Monitoring Extension
19th Feb 20207:00 amRNSExercise of Warrants and Issue of Equity
18th Feb 20204:30 pmRNSExercise of Warrants and Issue of Equity
18th Feb 20209:05 amRNSSecond Price Monitoring Extn
18th Feb 20209:00 amRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSExercise of Warrants and Issue of Equity
17th Feb 20204:40 pmRNSSecond Price Monitoring Extn
17th Feb 20204:35 pmRNSPrice Monitoring Extension
17th Feb 20202:06 pmRNSSecond Price Monitoring Extn
17th Feb 20202:00 pmRNSPrice Monitoring Extension
17th Feb 202012:30 pmRNSLaunch of CE-IVD Marked novel coronavirus test
17th Feb 202011:06 amRNSSecond Price Monitoring Extn
17th Feb 202011:00 amRNSPrice Monitoring Extension
17th Feb 20209:05 amRNSSecond Price Monitoring Extn
17th Feb 20209:00 amRNSPrice Monitoring Extension
14th Feb 20203:20 pmRNSUpdate on CE Mark Approved coronavirus test
14th Feb 202011:05 amRNSSecond Price Monitoring Extn
14th Feb 202011:00 amRNSPrice Monitoring Extension
11th Feb 20204:40 pmRNSSecond Price Monitoring Extn
11th Feb 20204:35 pmRNSPrice Monitoring Extension
11th Feb 20202:05 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:00 amRNSPrice Monitoring Extension
10th Feb 20202:05 pmRNSSecond Price Monitoring Extn
10th Feb 20202:01 pmRNSPrice Monitoring Extension
10th Feb 202011:05 amRNSSecond Price Monitoring Extn
10th Feb 202011:00 amRNSPrice Monitoring Extension
7th Feb 20204:40 pmRNSSecond Price Monitoring Extn
7th Feb 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.